Marinomed Biotech AG (STU:93Z) Market Cap : €27.58 Mil (As of Dec. 11, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Marinomed Biotech AG Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Marinomed Biotech AG's share price for the quarter that ended in Mar. 2024 was €21.5. Marinomed Biotech AG's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1.54 Mil. Therefore, Marinomed Biotech AG's market cap for the quarter that ended in Mar. 2024 was €33.12 Mil.

Marinomed Biotech AG's quarterly market cap declined from Sep. 2023 (€60.95 Mil) to Dec. 2023 (€46.32 Mil) and declined from Dec. 2023 (€46.32 Mil) to Mar. 2024 (€33.12 Mil).

Marinomed Biotech AG's annual market cap declined from Dec. 2021 (€129.07 Mil) to Dec. 2022 (€86.15 Mil) and declined from Dec. 2022 (€86.15 Mil) to Dec. 2023 (€46.32 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Marinomed Biotech AG's Enterprise Value for Today is €47.47 Mil.

Marinomed Biotech AG Market Cap Historical Data

The historical data trend for Marinomed Biotech AG's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG Market Cap Chart

Marinomed Biotech AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

145.51

170.83

129.07

86.15

46.32

Marinomed Biotech AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															54.84	58.34	60.95	46.32	33.12

Competitive Comparison of Marinomed Biotech AG's Market Cap

For the Biotechnology subindustry, Marinomed Biotech AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinomed Biotech AG's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's Market Cap distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's Market Cap falls into.

Marinomed Biotech AG Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Marinomed Biotech AG's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	€30.4	*	1.52383
	=	€46.32

Marinomed Biotech AG's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )	=	Share Price (Q: Mar. 2024 )	*	Shares Outstanding (EOP) (Q: Mar. 2024 )
	=	€21.5	*	1.54053
	=	€33.12

Marinomed Biotech AG (STU:93Z) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Marinomed Biotech AG Market Cap Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (STU:93Z) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

93Z:Germany MARI:Austria

Address

Hovengasse 25, Korneuburg, AUT, 2100

Website

https://www.marinomed.com

Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generated from the virology segment.

Marinomed Biotech AG Headlines

No Headlines